Revolution Medicines logo

Director, Clinical Operations

Revolution Medicines

Redwood City, CAHybridPosted 9 days ago$211,000 - $264,000/year
Full TimeDirector & AboveClinical DevelopmentBiotechnology
Original posting ↗

Summary

This is a unique opportunity for a Clinical Operations Professional who has innate leadership and organizational skills, technical expertise in clinical oncology drug development in an industry setting, and experience in overseeing clinical trials. As a director, you will be responsible for the Contract Research Organization (CRO) oversight, execution, and management of Revolution Medicines (RevMed) clinical trials.

Job description

The Opportunity

This is a unique opportunity for a Clinical Operations Professional who has innate leadership and organizational skills, technical expertise in clinical oncology drug development in an industry setting, and experience in overseeing clinical trials. As a director, you will be responsible for the Contract Research Organization (CRO) oversight, execution, and management of Revolution Medicines (RevMed) clinical trials.

Responsibilities

  • Adhere to Clinical Standard Operating Procedures (SOP) and Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) Guidelines.
  • Oversee the successful management of all aspects of clinical trials within timelines and designated program budgets.
  • Strategic thought partner on the development, management, and execution of the Clinical Development Plan (CDP) for assigned clinical programs which include timelines, budget, and resource requirements.
  • Ability to identify critical path activities and articulate and mitigate risks to clinical trial conduct.
  • Responsible for successful planning and deployment of Clinical Operations staff (potentially including Clinical Program Managers/Clinical Trial Managers/Clinical Trial Assistants, and consultants) for project and non-project related tasks.
  • Lead line management responsibilities that include hiring, performance management, career development, and mentorship.
  • Manage/oversee CROs and selected study vendors; ensuring all vendors strive to achieve the predetermined program milestones according to budget and timeline, as well as evaluating vendor performance using metrics and KPIs.
  • Lead team meetings and collaborate with other functional groups within the company (e.g., Clinical Development, Regulatory, QA, Finance, Legal, etc.) to achieve clinical study goals.
  • Ensure clinical trials maintain an inspection readiness state throughout the lifecycle of the trial.
  • Oversee the improvement of processes that will impact clinical trial management and deliverables including contingency plans by maintaining a highly effective Clinical Operations team and building strong relationships with functional leaders.

Required Skills, Experience and Education

  • RN or Bachelor's or Master's degree in biological sciences or health-related field required.
  • 15 years direct Clinical Operations experience in the pharmaceutical or biotech industry. Relevant indirect experiences may also meet the requirement.
  • Minimum of 9 years of project and first-line management experience.
  • Experience in leading and managing global phase 1-3 clinical trials within designated timelines, resources, and budgets.
  • Strong working knowledge of FDA Regulations, ICH Guidelines, and GCP.
  • Experience with vendor management and CRO oversight.
  • Ability to perform complex analysis, draw relevant conclusions, and implement appropriate solutions.
  • Ability to pivot, be solution-oriented with consideration to long-term impact on clinical trials, responsibilities, and inspection-readiness.
  • Strong analytical, negotiation, and persuasion skills.
  • Ability to deal with time demands, incomplete information, or unexpected events.
  • Outstanding organizational skills with the ability to multi-task and prioritize.
  • Excellent interpersonal, verbal, and written communication skills.
  • Decision-making skills.
  • Comfortable in a fast-paced company environment and able to adjust workload based upon changing priorities.
  • Demonstrate proficiency in Microsoft Office Suite (Outlook, MS Word, Excel, PowerPoint); MS Project and/or Smartsheet a plus.
  • Travel may be required (~25%).

Preferred Skills, Experience and Education

  • Proven success in collaborating with vendor systems/portals (e.g., eTMF, EDC, IRT, CTMS).
  • Oncology experience, early and/or late stage, strongly preferred.
  • Knowledge and/or familiarity with Ex-US region(s) clinical trial operations.
  • Experience in working with cooperative group studies and investigator sponsored trials preferred.

Requirements

  • RN or Bachelor's or Master's degree in biological sciences or health-related field required
  • 15 years direct Clinical Operations experience in the pharmaceutical or biotech industry
  • Minimum of 9 years of project and first-line management experience
  • Experience in leading and managing global phase 1-3 clinical trials within designated timelines, resources, and budgets
  • Strong working knowledge of FDA Regulations, ICH Guidelines, and GCP
  • Experience with vendor management and CRO oversight
  • Ability to perform complex analysis, draw relevant conclusions, and implement appropriate solutions
  • Strong analytical, negotiation, and persuasion skills
  • Outstanding organizational skills with the ability to multi-task and prioritize
  • Excellent interpersonal, verbal, and written communication skills
  • Decision-making skills
  • Proficiency in Microsoft Office Suite (Outlook, MS Word, Excel, PowerPoint)
  • Travel may be required (~25%)

Benefits

  • Competitive cash compensation
  • Robust equity awards
  • Strong benefits
  • Learning and development opportunities

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.